Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-242
Closed -$962K 726
2015
Q3
$962K Sell
242
-10,258
-98% -$668K 0.01% 175
2015
Q2
$705K Sell
10,500
-500
-5% -$32.6K 0.01% 375
2015
Q1
$644K Buy
11,000
+4,700
+75% +$284K 0.02% 346
2014
Q4
$412K Buy
6,300
+4,400
+232% +$277K 0.01% 509
2014
Q3
$110K Buy
1,900
+500
+36% +$27.8K ﹤0.01% 750
2014
Q2
$79K Buy
+1,400
New +$73.4K ﹤0.01% 664
2014
Q1
Sell
-5,600
Closed -$296K 720
2013
Q4
$296K Buy
+5,600
New +$275K 0.03% 464

Other funds holding ABBV

Jump Trading's ABBV Position: Q2 2020 in Review

Jump Trading reduced its AbbVie (ABBV) stake by 76% in Q2 2020, selling an estimated $594K and leaving 2,102 shares worth $206K. The position accounts for 0.14% of the portfolio, ranked #192.

Jump Trading first reported a position in ABBV in Q4 2013 and has held it in 11 quarters since. The position peaked at $692K in Q1 2015. 2,412 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Jump Trading held 2,102 shares of AbbVie worth $206K as of Q2 2020.
  • Jump Trading sold 6,744 AbbVie shares in Q2 2020, an estimated $594K.
  • AbbVie made up 0.14% of Jump Trading's portfolio in Q2 2020, its #192 holding.
  • Jump Trading first reported a position in AbbVie in Q4 2013 and has held it in 11 quarters since.
  • Jump Trading's AbbVie position peaked at $692K in Q1 2015.
  • 2,412 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.